과제정보
This work was supported by Dong-eui University foundation grant 2022, I thank professor Jeong-Hwan Shin of Inje University Busan Paik Hospital for his help in collecting strains.
참고문헌
- Andes D, Ogtrop ML, Peng J, Craig WA. In vivo pharmacodynamics of a new oxazolidinone (linezolid). Antimicrob Agents Chemother. 2002. 46: 3484-3489.
- Attassi K, Hershberger E, Alam R, Zervos MJ. Thrombocytopenia associated with linezolid therapy. Clin Infect Dis. 2002. 34: 695-698.
- Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Tests; approved standards M2-M11, 28th ed. Wayne PA: CLSI; 2018.
- Hong EJ, Na KJ, Choi IG, Choi KC, Jeung EB. Antibacterial and antifungal effects of essential oils from coniferous trees. Biol Pham Bull. 2004. 27: 863-866.
- Jones RN, Ross JE, Bell JM, Utsuki U, Fumiaki I, Kobaysashi I, Trunidge JD. Zyvox annual appraisal of potency and spectrum program: linezolid surveillance program results for 2008. Diagn Microbiol Infect Dis. 2009. 65: 404-413.
- Kato H, Hagihara M, Asai N, Shibata Y, Koizumi Y, Yamagishi Y, Mikamo H. Meta-analysis of vancomycin versus linezolid in pneumonia with proven methicillin-resistant Staphylococcus aureus. J Glob Antimicrob Resist. 2021. 24: 98-105.
- Lee JH, Lee BK, Kim JH, Lee SH, Hong SK. Comparison of chemical compositions and antimicrobial activities of essential oils from three conifer trees; Pinus densiflora, Cryptomeria japonica, and Chamaecyparis obtuse. J Microiol Biotechnol. 2009. 19: 391-396.
- Lee JW, Yoon JH, Park JW. Effect of grapefruit seed extract fir abtubacteruak activity on the coated packaging. Food Eng Prog. 2015. 19: 104-110.
- Shinabarger D. Mechanism of action of the oxazolidinone antibacterial agents. Expert Opin Investig Drugs. 1999. 8: 1195-1202.
- Yang JK, Choi MS, Seo WT, Rinker DL, Han SW, Cheong GW. Chemical composition and antimicrobial activity of Chamaecyparis obtuse leaf essential oil. Fitoterapia. 2007. 78: 149-52.
- Yum JH, Choi SH, Yong D, Chong Y, Im WB, Rhee DK, Lee K. Comparative In vitro activities of torezolid (DA-7157) against clinical isolates of aerobic and anaerobic bacteria in South Korea. Antimicrob Agents Chemother. 2010. 54: 5381-5386.